Home / Intelligence / Webinars / How to Develop Strong Evidence to Enable Optimal Access Recording
Available On Demand
![](https://trinitylifesciences.com/wp-content/uploads/2021/05/Trinity-Webinar-How-to-Develop-Strong-Evidence-to-Enable-Optimal-Access-1024x535.jpg)
Communicating a compelling value story to clinicians and payers is key to launching a product successfully and optimizing value throughout the product lifecycle.
- But how exactly does one generate evidence that will educate stakeholders on the disease state, shape the future market and support your value narrative?
- What are the ‘nuts and bolts’ of designing and conducting such studies?
- How do you distill down to the key value messages from a complex data set to be most impactful to clinical and payer audiences?
Learn how Burden of Illness studies are conducted and how this study type could support your disease areas! The Trinity team will highlight the importance of evidence generation through the lens of a scientific Burden of Illness study that we recently conducted with a global pharma company. Beyond the scientific implications of studies of this kind, we will delve into the real-world applications of this evidence from a market access perspective.
Please complete the form to watch our Trinity Webinar: How to Develop Strong Evidence to Enable Optimal Access.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Related Intelligence
Webinars
Looking Ahead to the November Election and Beyond
August 14, 2024 | 1:00 – 2:00 PM ET
As healthcare policy and the access landscape evolve, biopharma companies face challenges in navigating this ever-changing space. To help organizations prepare for and adapt to these changes, Trinity Life Sciences is offering a new webinar series, The Next Era in U.S. Healthcare Policy & Access. Join us for the first webinar in the series, Looking Ahead […]
Sign Up Now
Blog
Developing Effective Global Value Dossiers
Trinity Life Sciences recently worked with a large global pharma company to develop a new process for creating global value dossiers (GVDs) that better met the needs of regional affiliates. Matt O’Hara, who leads Trinity’s Evidence Strategy practice, shares insights into the project with Mary Fletcher-Louis, who recently joined Trinity to head Trinity’s Value Center […]
Read More
Blog
Rise with the Waves: UK – Now and Beyond – Four Policy Trends That May Shape Pharma’s Future
Executive Summary The global payer landscape is rapidly evolving and is expected to continuously impact manufacturers’ decisions about new launches, portfolio management, trial design and importantly, pricing and market access strategy. In the UK, several policy reforms have been introduced which are expected to improve patient access while balancing financial healthcare sustainability and overall market […]
Read More